What is Adagene Inc?
, a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 118.17M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 222,290 shares $70k |
| 3-6months | 0 | 12,000 shares $8k |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |